Development and Applica0on of Real- Time Clinical Predic0ve Models

Size: px
Start display at page:

Download "Development and Applica0on of Real- Time Clinical Predic0ve Models"

Transcription

1 Development and Applica0on of Real- Time Clinical Predic0ve Models Ruben Amarasingham, MD, MBA Associate Professor, UT Southwestern Medical Center AHRQ- funded R24 UT Southwestern Center for Pa?ent- Centered Outcomes Research CEO, Parkland Center for Clinical Innova?on Date: Monday, December 1, 2015 Time: 12:00 1:00pm

2 Objec?ves Background: Predic?on and the Prac?ce of Medicine A Taxonomy for Predic?on and Decision Support Applica?on to Readmissions Further Considera?ons Q&A 2

3 What We Do in Medicine: Predic?on 1. What does this pa?ent have? 2. What will this pa?ent develop? 3. What will be the effect of a given therapy? 3

4 Predic?on in the Context of Modern Medicine Staggering increase in medical informa?on Increasing volume of decisions at mul?ple levels High fragmenta?on of care Increasing capacity for error 4

5 Glimmers of a New Age in Medicine Massive data capture Real-?me precision monitoring Vast computa?onal power Natural Language Processing Machine Learning 5

6 A Modified Taxonomy Term Predic?on Rule Decision Rule Decision Analysis Decision Support Prac?ce Guidelines e- Health Predic?ve Analysis Defini0on Provides diagnos?c or prognos?c probabili?es; does not recommend decision. Predic?on rule sufficiently validated to recommend decisions Quan?fies value of specified outcomes from published literature; health policy Designed to prevent errors when implemen?ng decisions already made Address several issues for pa?ents with a par?cular syndrome; ocen consensus based Technologies or socware systems that can autonomously employ and some?mes reengineer, modify, or update clinical risk predic?on models Reilly BM et al. Annals of Internal Medicine 2006;144: Amarasingham R et al. Health Affairs

7 Clinical Applica?on of Predic?ve Analy?cs for Different Condi?ons and?meframe Hours 30 days 90 days Years Cardio- Pulmonary Arrest Sepsis Pa?ent Safety Event Surgical Complica?on Readmissions All- Cause AMI CHF PNA HIV Cirrhosis 7 Short- Term Diabe?c Complica?ons Chronic Kidney Disease Preventable DM Admissions

8 Predic?ng 30- Day Readmission in Heart Failure in Real- Time Heart failure readmissions are common, costly, and many are poten?ally preventable EMR- based readmission models are promising: Can tap many domains of risk Produce ac?onable intelligence usable in real-?me New domains of interest include: Socio- demographics, mental health/substance abuse, social disadvantage 8

9 Conceptual Model and Program Theory 9

10 Modeling HF Severity of Illness Model: Age, Albumin, T bili, CK, Crea?nine, Na, BUN, pco2, WBC, TN- I, Glucose, INR, BNP, ph, Temp, Pulse, Diastolic BP, Systolic BP (deriva?on=273, 034; valida?on=629,400) Tabak et al, Medical Care,

11 Odds Ra?os for 30 Day Readmission for Final Model Variables Variable 11 Multivariate OR (95% CI) Tabak Mortality Score (composite) 1.52 ( ) Single 1.44 ( ) Male 1.37 ( ) Number of Home Address Changes 1.13 ( ) Medicare 1.59 ( ) Residence in low SES census tract 1.38 ( ) History of documented cocaine use 1.78 ( ) History of missed clinic visit 1.35 ( ) Used a health system pharmacy 0.72 ( ) Number of prior inpatient admissions 1.17 ( ) Presentation time (day or night) 1.38 ( ) History of Depression or Anxiety 1.44 ( )

12 Performance of Electronic Heart Failure Model (N=1372, C- Stat 0.72) Derivation Samples Validation Samples Very Low Low Intermediate High Very High Predicted Readmission Risk Category 12 Amarasingham et al, Medical Care, 2010

13 From Predic?on to Ac?on: HF Interven?on Challenges & Solu?ons Iden?fy HF pa?ents in the first 24 hrs of admission Ocen no defini?ve admission diagnosis (SOB, edema, cough) Natural language processing to flag cases Too many pa?ents & too expensive to try to do everything on everyone Iden?fy those at highest risk to get enhanced suite of inpa?ent & outpa?ent interven?ons Provide electronic surveillance, coordina?on, & tracking of interven?on processes of care & outcomes 13

14 Readmission Preven?on Interven?on Workflow Admission Discharge 30 Days 90 Days 24 hours 7 days ID Risk List Orders Inpatient Intervention 5 5 Outpatient Intervention Evaluation & Improvement 6 Electronic Medical Record Real- Time HL7 based interface EMR applica0on 14

15 Interven?on Results: 26% Rela?ve Reduc?on in Odds of Readmission Results Demonstrated: Concentrated care management efforts on ¼ of the pa?ents 26% rela?ve reduc?on in odds of readmission Absolute reduc?on of 5 readmissions per 100 index admissions Saved hospital $1 million 15

16 Compara?ve Effec?veness of Different Models for Predic?ng Readmissions 1. EMR- based v. administra?ve claims models 2. Develop & validate an all- cause, mul?- condi?on model 3. First- day v. full- stay models 4. Mul?- condi?on generic v. disease- specific models 5. Customizing models to individual hospitals, data systems, pa?ent popula?ons 16

17 Develop and Validate an All- Cause, Real- Time, Mul?- condi?on model 40 Derivation cohort Validation cohort group 1 group 2 group 3 group 4 group 5 Predicted Risk Category Amarasingham et al. Under Review,

18 EMR All Cause model versus CMS and LACE models 18

19 All- Cause 30- Day Readmission Model Full Hospital Stay versus First Day (n=16430) Predicted Risk, % C- sta?s?c (95% CI) Lowest Highest All- cause full- stay Deriva0on cohort ( ) 4 37 Valida0on cohort ( ) 4 37 All- cause 24- hour ( ) 6 32 Other models: LACE* ( ) 6 28 HOSPITAL model ( ) 7 27 CMS HWR ( )

20 Other Considera?ons 1. Interven?ons for highest risk pa?ents 2. Considering clinical vs. social risk 3. Explana?on vs. Predic?on 4. Non- health care data sources 5. Changing EMR data models 6. Changing clinical interven?ons 7. Changing popula?ons 20

21 Larger Complexi?es of Predic?ve Modeling in Healthcare 21

22 Clinical Applica?on of Predic?ve Analy?cs for Different Condi?ons and?meframe Hours 30 days 90 days Years Cardio- Pulmonary Arrest Sepsis Pa?ent Safety Event Surgical Complica?on Readmissions All- Cause AMI CHF PNA HIV Cirrhosis 22 Short- Term Diabe?c Complica?ons Chronic Kidney Disease Preventable DM Admissions

23 Conclusions Predic?ve analy?cs are a promising way to help improve?meliness, safety and quality in health care; CHF model and interven?on are an example of successful implementa?on of predic?ve analy?cs in real- world setng; All Cause, Mul?- Condi?on Readmission Model has poten?al to have more significance for applica?on; Many challenges remain in methodology, applica?on and policy for electronic predic?ve analysis to thrive. 23

24 Ques?ons Contact Informa0on: Ruben Amarasingham 24

Learning Objec1ves. Study Design Considera1ons in Clinical Pharmacy

Learning Objec1ves. Study Design Considera1ons in Clinical Pharmacy 9/28/15 Study Design Considera1ons in Clinical Pharmacy Ludmila Bakhireva, MD, PhD, MPH Pree Sarangarm, PharmD, BCPS Learning Objec1ves Describe the features, advantages and disadvantages of the observa1onal

More information

Learning Objec1ves. Study Design Strategies. Cohort Studies 9/28/15

Learning Objec1ves. Study Design Strategies. Cohort Studies 9/28/15 9/28/15 Learning Objec1ves Describe the features, advantages and disadvantages of the observa1onal study designs Explain why the overall study design is important when evalua1ng studies & applying their

More information

Biosta's'cs Board Review. Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016

Biosta's'cs Board Review. Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016 Biosta's'cs Board Review Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016 Review key biosta's'cs concepts Understand 2 X 2 tables Objec'ves By the end of this

More information

Economic outcomes: Method for implementa5on

Economic outcomes: Method for implementa5on Economic outcomes: Method for implementa5on Philippe Beutels Centre for Health Economics Research & Modelling Infec

More information

Common Data Elements: Making the Mass of NIH Measures More Useful

Common Data Elements: Making the Mass of NIH Measures More Useful Common Data Elements WG Common Data Elements: Making the Mass of NIH Measures More Useful Jerry Sheehan Assistant Director for Policy Development Na?onal Library of Medicine Gene/c Alliance Webinar Series

More information

Welcome! Pragmatic Clinical Studies. David Hickam, MD, MPH Program Director Clinical Effectiveness Research. David Hickam, MD, MPH

Welcome! Pragmatic Clinical Studies. David Hickam, MD, MPH Program Director Clinical Effectiveness Research. David Hickam, MD, MPH Pragmatic Clinical Studies David Hickam, MD, MPH Program Director Clinical Effec2veness Research June 23, 2015 Welcome! David Hickam, MD, MPH Program Director Clinical Effectiveness Research 2 In this

More information

A review of approaches to identifying patient phenotype cohorts using electronic health records

A review of approaches to identifying patient phenotype cohorts using electronic health records A review of approaches to identifying patient phenotype cohorts using electronic health records Shivade, Raghavan, Fosler-Lussier, Embi, Elhadad, Johnson, Lai Chaitanya Shivade JAMIA Journal Club March

More information

Addressing the Challenge of Medica3on Adherence. Jan Berger MD, MJ President and CEO Health Intelligence Partners

Addressing the Challenge of Medica3on Adherence. Jan Berger MD, MJ President and CEO Health Intelligence Partners Addressing the Challenge of Medica3on Adherence Jan Berger MD, MJ President and CEO Health Intelligence Partners Drugs Have Become the Mainstay of Healthcare Treatment America s Other Drug Problem Non-adherence

More information

Frailty in Geriatric Trauma Pa1ents

Frailty in Geriatric Trauma Pa1ents Division of Trauma, Burn, Surgical Critical Care, & Emergency General Surgery Frailty in Geriatric Trauma Pa1ents Zara Cooper, MD, MSc, FACS Elizabeth Bryant, MPH Disclosures NIA R01AG044518 NCI R35CA197730

More information

Identifying Engineering, Clinical and Patient's Metrics for Evaluating and Quantifying Performance of Brain- Machine Interface Systems

Identifying Engineering, Clinical and Patient's Metrics for Evaluating and Quantifying Performance of Brain- Machine Interface Systems Identifying Engineering, Clinical and Patient's Metrics for Evaluating and Quantifying Performance of Brain- Machine Interface Systems Jose Pepe L. Contreras-Vidal, Ph.D. Department of Electrical & Computer

More information

Department of Emergency Office of Research. Shannon McNabb, MA, MPH Clinical Research Manager January 2017

Department of Emergency Office of Research. Shannon McNabb, MA, MPH Clinical Research Manager January 2017 Department of Emergency Medicine Office of Research Shannon McNabb, MA, MPH Clinical Research Manager January 2017 EM Study Tracking System UPDATED ON: 12/5/2016 TOTAL 68 Grants Submitted, Award Pending

More information

Chronic Kidney Disease

Chronic Kidney Disease Chronic Kidney Disease Management Issues in the Hospital and Beyond in pre dialysis CKD pa;ents Brian Wolfe, MD Assistant Professor of Medicine University of Colorado Denver, Hospital Medicine Sec;on Case:

More information

Findings from the At Home / Chez Soi Demonstration Project in Canada. Paula Goering and Catharine Hume May 2, 2013

Findings from the At Home / Chez Soi Demonstration Project in Canada. Paula Goering and Catharine Hume May 2, 2013 Findings from the At Home / Chez Soi Demonstration Project in Canada Paula Goering and Catharine Hume May 2, 2013 Outline for today Overview of Project Design Na8onal level findings re one year outcomes

More information

A large database study in the general population in England

A large database study in the general population in England Time-dependent markers of comorbidity severity and change are associated with increased risk of mortality in heart failure: A large database study in the general population in England Claire A. Rushton,

More information

For more information about how to cite these materials visit

For more information about how to cite these materials visit Author(s): Rajesh Mangrulkar, M.D., 2013 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Non-commercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/

More information

Engage and Empower Pa.ents with Interac.ve Technology. Northeast NAHAM Regional Conference Pa.ent Access: GeBng It Right Upfront October 22-23, 2012

Engage and Empower Pa.ents with Interac.ve Technology. Northeast NAHAM Regional Conference Pa.ent Access: GeBng It Right Upfront October 22-23, 2012 Engage and Empower Pa.ents with Interac.ve Technology Northeast NAHAM Regional Conference Pa.ent Access: GeBng It Right Upfront October 22-23, 2012 NAHAM - Pa.ent Access Services 2 Pa%ent Access Services

More information

2015 Na(onal Medicaid and CHIP Oral Health Symposium

2015 Na(onal Medicaid and CHIP Oral Health Symposium MSDA Medicaid CHIP State Dental Association 2015 Na(onal Medicaid and CHIP Oral Health Symposium Session # 9 Primary Care Physician Integra(on into Dental Program An(cipatory Guidance, Screening & Care

More information

Public Health / Public Works Introduc6on, reitera6on + Lessons 1-2. Pioneer Winter IDH 3034, IDH 4007

Public Health / Public Works Introduc6on, reitera6on + Lessons 1-2. Pioneer Winter IDH 3034, IDH 4007 Public Health / Public Works Introduc6on, reitera6on + Lessons 1-2 Pioneer Winter IDH 3034, IDH 4007 What s the purpose of this class? Learning Objec6ves Understand the principles of public health, epidemiology,

More information

Heart Failure - Large Market Opportuni4es for New Biomarkers

Heart Failure - Large Market Opportuni4es for New Biomarkers Heart Failure - Large Market Opportuni4es for New Biomarkers Integra4on of Market and Clinical Research Previously Presented Publicly Predominantly in 2011 Heart Failure Pa4ent Sta4s4cs Show Large Unmet

More information

Design, Conduct and Analysis of Pragma?c Clinical Trials in Pallia?ve Care Research

Design, Conduct and Analysis of Pragma?c Clinical Trials in Pallia?ve Care Research Design, Conduct and Analysis of Pragma?c Clinical Trials in Pallia?ve Care Research Sco$ D. Halpern, M.D., Ph.D. Associate Professor of Medicine, Epidemiology, and Medical Ethics & Health Policy Director,

More information

Leveraging the HSX Clinical Data Repository to Improve Behavioral Health Care:

Leveraging the HSX Clinical Data Repository to Improve Behavioral Health Care: Leveraging the HSX Clinical Data Repository to Improve Behavioral Health Care: Insights from the Montgomery County Hospital Partnership HEALTHSHARE EXCHANGE BOARD OF TRUSTEES ANNUAL MEETING NOVEMBER 14,

More information

3/31/2015. Designing Clinical Research Studies: So You Want to Be an

3/31/2015. Designing Clinical Research Studies: So You Want to Be an Designing Clinical Research Studies: So You Want to Be an Inves@gator Andrea Bonny, MD Ellen Lançon Connor, MD On behalf Of The NASPAG Research CommiPee Objec@ves Learn to design a clinical research project

More information

Perspec'vas Psicologicas en el Cuidado de la Diabetes

Perspec'vas Psicologicas en el Cuidado de la Diabetes Perspec'vas Psicologicas en el Cuidado de la Diabetes Antonio E. Puente University of North Carolina Wilmington Universidad de la Ciudad de Juarez 09.20.13 Health Sta's'cs: 2010 (The Economist, 12.12.09)

More information

Pragma&c Clinical Trials

Pragma&c Clinical Trials Pragma&c Clinical Trials Susanne May, PhD Associate Professor Department of Biosta&s&cs, School of Public Health, University of Washington Preliminaries PLEASE ask ques&ons at any &me REALLY good clinical

More information

Mental Health, Substance Abuse & Primary Care: Bridging Gaps in Access

Mental Health, Substance Abuse & Primary Care: Bridging Gaps in Access 1 Mental Health, Substance Abuse & Primary Care: Bridging Gaps in Access Christopher Carroll, Director, Health Care Financing and Systems Integration Substance Abuse and Mental Health Services Administration

More information

Designing and Delivering ACT Interven2ons for Individuals with Medical Condi2ons:

Designing and Delivering ACT Interven2ons for Individuals with Medical Condi2ons: ACBS Symposium World Con 12 Designing and Delivering ACT Interven2ons for Individuals with Medical Condi2ons: Transdiagnos2c principles and key change processes Megan Oser, PhD Vanessa Alvarez, MA Gabe

More information

Session 13 Objec+ves MSDA Na+onal Medicaid and CHIP Oral Health Symposium June 24 th 26 th, 2012

Session 13 Objec+ves MSDA Na+onal Medicaid and CHIP Oral Health Symposium June 24 th 26 th, 2012 2012 MSDA Na+onal Medicaid and CHIP Oral Health Symposium June 24 th 26 th, 2012 Session 13 Dental Quality Alliance Update Krishna Aravamudhan, BDS, MS (DQA) Martha Dellapena (MSDA) Session 13 Objec+ves

More information

Independence Well- being and Choice 2005, Our health, our care, our say 2006, Strong and Prosperous 2006

Independence Well- being and Choice 2005, Our health, our care, our say 2006, Strong and Prosperous 2006 Medicines Op+misa+on Outcome focused approach to safe and effec+ve use of medicines that takes into account the pa+ent s values, percep+on and experience of taking their medicines Important Outcomes for

More information

Oncology Care Model Overview

Oncology Care Model Overview Oncology Care Model Overview Centers for Medicare & Medicaid Services Innova3on Center (CMMI) September 2017 Innova3on at CMS Center for Medicare & Medicaid Innova3on (Innova3on Center) Established by

More information

A Trial Implementa.on of a High Density Health Informa.on Exchange Standard: Are We Ready for Coordinated Care in High Impact Condi.ons?

A Trial Implementa.on of a High Density Health Informa.on Exchange Standard: Are We Ready for Coordinated Care in High Impact Condi.ons? A Trial Implementa.on of a High Density Health Informa.on Exchange Standard: Are We Ready for Coordinated Care in High Impact Condi.ons? Michael Hogarth, MD, FACP CMIO, Athena Breast Health Network Professor,

More information

Considera*ons when undergoing personal genotyping

Considera*ons when undergoing personal genotyping Considera*ons when undergoing personal genotyping Kelly Ormond, MS, CGC Louanne Hudgins, MD, FACMG January 19, 2011 GENE 210 Disclosures and introduc*ons Professor Ormond provided paid consulta*on for

More information

Fall & Injury Preven/on: Demen/a + Hospitals = The Perfect Storm

Fall & Injury Preven/on: Demen/a + Hospitals = The Perfect Storm Fall & Injury Preven/on: Demen/a + Hospitals = The Perfect Storm Tiffany E. Shubert, PhD, PT Carolina Geriatric Educa/on Consor/um UNC School of Medicine June 11, 2014 Acknowledgements This work was supported

More information

Managing the U+liza+on of CT and MR Studies in an Era of Precer+fica+on

Managing the U+liza+on of CT and MR Studies in an Era of Precer+fica+on Managing the U+liza+on of CT and MR Studies in an Era of Precer+fica+on Steven E. Seltzer, M.D. Department of Radiology Brigham and Women s Hospital Harvard Medical School Boston, MA COI Disclosure - Partners

More information

Evidence- based Catheter Associated Urinary Tract Infec8on CAUTI Preven8on. Effec%ve CAUTI Preven%on Saves Lives, Prevents Harm, and Reduces Costs

Evidence- based Catheter Associated Urinary Tract Infec8on CAUTI Preven8on. Effec%ve CAUTI Preven%on Saves Lives, Prevents Harm, and Reduces Costs Evidence- based Catheter Associated Urinary Tract Infec8on CAUTI Preven8on Effec%ve CAUTI Preven%on Saves Lives, Prevents Harm, and Reduces Costs Maureen Dailey, PhD, RN, CWOCN CMS Leadership to Reduce

More information

Blue Cross Blue Shield of Michigan Building a Statewide PCMH Program: Design, Evalua>on Methods, and Results

Blue Cross Blue Shield of Michigan Building a Statewide PCMH Program: Design, Evalua>on Methods, and Results Blue Cross Blue Shield of Michigan Building a Statewide PCMH Program: Design, Evalua>on Methods, and Results Margaret Mason, MHSA Michael Paus6an, PhD, MS Amanda Markovitz, MPH 1 Overview of BCBSM Serving

More information

Prédire la récupéra1on rénale. Michaël DARMON Réanima1on polyvalente CHU de Saint- E1enne

Prédire la récupéra1on rénale. Michaël DARMON Réanima1on polyvalente CHU de Saint- E1enne Prédire la récupéra1on rénale Michaël DARMON Réanima1on polyvalente CHU de Saint- E1enne Non- specific AKI in the ICU Lameire et al. Lancet 2005 The classical view Intense renal vasoconstric1on r= - 0.82;

More information

Illinois Accountability Technical Advisory Committee (TAC) Academic Growth for Accountability

Illinois Accountability Technical Advisory Committee (TAC) Academic Growth for Accountability Illinois Accountability Technical Advisory Committee (TAC) Academic December 18-19, 2017 Questions for the TAC What model features and characteris@cs are most important? What evidence should be collected

More information

Caring for cancer patients with comorbidity. Chair: Associate Professor Diana Sarfa3

Caring for cancer patients with comorbidity. Chair: Associate Professor Diana Sarfa3 Caring for cancer patients with comorbidity Chair: Associate Professor Diana Sarfa3 Why do we care? Comorbidity: is common among cancer pa3ents. has a major impact on pa3ents. has a major impact on health

More information

How does a heart surgeon prevent a heart a>ack?

How does a heart surgeon prevent a heart a>ack? How does a heart surgeon prevent a heart a>ack? Michael Richman M.D., F.A.C.S. CEO and Director, The Center for Cholesterol Management Los Angeles, California www.lipidcenter.com Heart disease: #1 killer

More information

Decision Support. HAP 752 Advanced Health Informa6on Systems. Janusz Wojtusiak, PhD George Mason University Spring 2014

Decision Support. HAP 752 Advanced Health Informa6on Systems. Janusz Wojtusiak, PhD George Mason University Spring 2014 Decision Support HAP 752 Advanced Health Informa6on Systems Janusz Wojtusiak, PhD George Mason University Spring 2014 Evidence does not make decisions, people do. - Haynes, Devereaux, GuyaQ (BMJ 2002)

More information

Big Data Science and Analytics in Health and Biomedicine

Big Data Science and Analytics in Health and Biomedicine References Big Data Science and Analytics in Health and Biomedicine William Hersh, MD, FACP, FACMI Professor and Chair Department of Medical Informatics & Clinical Epidemiology Oregon Health & Science

More information

Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital:

Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital: Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital: Eugenio H. Zabaleta, Ph.D. Clinical Chemist OhioHealth Mansfield Hospital Reducing Readmissions and Improving Outcomes at

More information

Preven'ng AKI. Lessons from Contrast-associated AKI It s all about urine output

Preven'ng AKI. Lessons from Contrast-associated AKI It s all about urine output Preven'ng AKI Lessons from Contrast-associated AKI It s all about urine output CASE A 76 y/o male comes to the ED complaining of substernal crushing chest pain. The pain started a few hours ago while he

More information

Pa#ern recogni,on and neuroimaging in psychiatry

Pa#ern recogni,on and neuroimaging in psychiatry Pa#ern recogni,on and neuroimaging in psychiatry Janaina Mourao-Miranda Machine Learning and Neuroimaging Lab Max Planck UCL Centre for Computa=onal Psychiatry and Ageing Research Outline Supervised learning

More information

Psychological outcomes of cri2cal illness for pa2ents and family members. Erin K. Kross, MD Summer Lung Day June 18, 2010

Psychological outcomes of cri2cal illness for pa2ents and family members. Erin K. Kross, MD Summer Lung Day June 18, 2010 Psychological outcomes of cri2cal illness for pa2ents and family members Erin K. Kross, MD Summer Lung Day June 18, 2010 Outline Overview of psychological outcomes for pa2ents and family members ager cri2cal

More information

Medication Adherence Campaign Target Market Tracking Survey Results National Consumers League October 9, 2015

Medication Adherence Campaign Target Market Tracking Survey Results National Consumers League October 9, 2015 Medication Adherence Campaign Target Market Tracking Survey Results National Consumers League October 9, 2015 Objectives An ini%al target market survey was launched in May 2011 to serve as a benchmark

More information

Upper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines.

Upper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines. Upper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines Chris,ne McDonough, PhD, PT, CEEAA Health Outcomes Unit Department of Health

More information

Tackling Tobacco Through Re-engineered Primary Care

Tackling Tobacco Through Re-engineered Primary Care 2/27/18 Tackling Tobacco Through Re-engineered Primary Care Daren Wu, M.D. Chief Medical Officer Learning Objec>ves Understand the key stumbling blocks that can interfere with tobacco screening and treatment,

More information

Aggressive Medical Management with or without Angioplasty and Sten8ng for Symptoma8c Intracranial Atherosclero8c Stenosis: Long Term Results

Aggressive Medical Management with or without Angioplasty and Sten8ng for Symptoma8c Intracranial Atherosclero8c Stenosis: Long Term Results Aggressive Medical Management with or without Angioplasty and Sten8ng for Symptoma8c Intracranial Atherosclero8c Stenosis: Long Term Results Disclosures Funding by NINDS U01 NS058728 Boston Scien8fic provided

More information

Medical informa.on, flow and building rapid learning cancer knowledge centers

Medical informa.on, flow and building rapid learning cancer knowledge centers Medical informa.on, flow and building rapid learning cancer knowledge centers Craig Nichols, MD Visi.ng Professor Bri.sh Columbia Cancer Agency Director- Tes.cular Cancer Consor.um LIVESTRONG- Health Informa.on

More information

C-reac've protein-based TB screening

C-reac've protein-based TB screening C-reac've protein-based TB screening Advanced TB Diagnos0cs Workshop June 22, 2017 Chris0na Yoon, MD, MPH University of California, San Francisco Systema'c TB screening Recommendations 1-3 Should be done:

More information

USING EVIDENCE FOR HEMATOLOGY LABORATORY PRACTICE. Alfonso Iorio McMaster University, Canada

USING EVIDENCE FOR HEMATOLOGY LABORATORY PRACTICE. Alfonso Iorio McMaster University, Canada USING EVIDENCE FOR HEMATOLOGY LABORATORY PRACTICE Alfonso Iorio McMaster University, Canada Disclosures Financial No relevant rela1onships to disclose Research funding in the field of hemophilia care Intellectual

More information

F. Bochicchio The approach of the INRAP for preven8on and mi8ga8on and the new Direc8ve on BSS. Radon Protec8on Conf. Dresden, 2 3 Dec.

F. Bochicchio The approach of the INRAP for preven8on and mi8ga8on and the new Direc8ve on BSS. Radon Protec8on Conf. Dresden, 2 3 Dec. Radon protec8on conference New challenges for the European construc8on and ven8la8on branches of Europe Dresden (Sachsen, Germany) December 2 nd 3 rd 2013 The approach of the Italian Na1onal Radon Ac1on

More information

The Canadian Landscape of PaAent Reported Outcome and Experience Measures. Santana MJ, MPharm, PhD October 17, 2016, Amsterdam

The Canadian Landscape of PaAent Reported Outcome and Experience Measures. Santana MJ, MPharm, PhD October 17, 2016, Amsterdam The Canadian Landscape of PaAent Reported Outcome and Experience Measures Santana MJ, MPharm, PhD October 17, 2016, Amsterdam Canada & Netherlands: The Tulip Legacy Outline Overview -- Na+onal strategy

More information

The Availability of Homeopathic Medicinal Products (HMPs) in Europe with reference to the Matrix Report

The Availability of Homeopathic Medicinal Products (HMPs) in Europe with reference to the Matrix Report The Availability of Homeopathic Medicinal Products (HMPs) in Europe with reference to the Matrix Report A presenta@on to the European Parliament CAM Interest Group 1 July 2015 By Stephen Gordon General

More information

Preparing Pre-health Professional Students & Advisors for the Mul8ple Mini-Interviews: Advanced Issues

Preparing Pre-health Professional Students & Advisors for the Mul8ple Mini-Interviews: Advanced Issues Preparing Pre-health Professional Students & Advisors for the Mul8ple Mini-Interviews: Advanced Issues Robert Klitzman, MD Professor of Psychiatry Director, Bioethics Masters & Online Certificate & Course

More information

Health Informa.cs. Lecture 9. Samantha Kleinberg

Health Informa.cs. Lecture 9. Samantha Kleinberg Health Informa.cs Lecture 9 Samantha Kleinberg samantha.kleinberg@stevens.edu Next week: journal club For all papers: read, and prepare to comment on For your paper: Read the ar.cle (+ other references

More information

Resolving the PSA testing controversy. Professor Villis Marshall AC Professor Bruce Armstrong AM Professor Mark Frydenberg

Resolving the PSA testing controversy. Professor Villis Marshall AC Professor Bruce Armstrong AM Professor Mark Frydenberg Resolving the PSA testing controversy Professor Villis Marshall AC Professor Bruce Armstrong AM Professor Mark Frydenberg Professor Villis Marshall AC Introduc)on Guidelines aim to inform tes)ng for the

More information

Documenting in the World of ICD-10 Capturing all your CCs and MCCs Crystal Coen, RN, MSN, FNP-BC NPSS Asheville, NC

Documenting in the World of ICD-10 Capturing all your CCs and MCCs Crystal Coen, RN, MSN, FNP-BC NPSS Asheville, NC Documenting in the World of ICD-10 Capturing all your CCs and MCCs Crystal Coen, RN, MSN, FNP-BC 2017 NPSS Asheville, NC Objectives Understand the importance of documenting to the highest specificity Understand

More information

Finding and Using Local Data for Suicide Preven7on

Finding and Using Local Data for Suicide Preven7on Finding and Using Local Data for Suicide Preven7on January 21 st, 2014 1 Welcome! Please mute your phone or microphone line If you have a ques7on, please type it into the Ques7ons box or raise your hand

More information

1/24/15. In pursuit of evidence- based prac8ce. Accessibility of Available Evidence. Today s Purpose BUT FIRST... Levels of Evidence (LOE)

1/24/15. In pursuit of evidence- based prac8ce. Accessibility of Available Evidence. Today s Purpose BUT FIRST... Levels of Evidence (LOE) Speeding Up the EBP Process: Using Evidence that is Appraised, Available, and Ready To Go In pursuit of evidence- based prac8ce Clinician s best judgment How do we gain access to available evidence? Cailee

More information

Causal Inference from Complex Observa4onal Data. Samantha Kleinberg

Causal Inference from Complex Observa4onal Data. Samantha Kleinberg Causal Inference from Complex Observa4onal Data Samantha Kleinberg samantha.kleinberg@stevens.edu Three key points We need causal knowledge Causes are hard to find It s not hopeless! Most striking, society

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Readmission Measures Set

More information

Genetic Tests and Genetic Counseling How to Analyze Your Own Genome

Genetic Tests and Genetic Counseling How to Analyze Your Own Genome Genetic Tests and Genetic Counseling 02-223 How to Analyze Your Own Genome Genetic Tests for Huntington Disease Hun7ngton Disease Incurable brain disorder that runs in families Movement, cogni7ve, and

More information

Hospital Transition Management. Barbara Wood, BSN, MBA

Hospital Transition Management. Barbara Wood, BSN, MBA Hospital Transition Management Barbara Wood, BSN, MBA Director, Embedded Care Management Programs OBJECTIVES Improve health care quality for our patients by streamlining care transitions Reduce avoidable

More information

Effec&ve Messaging for Suicide Preven&on:

Effec&ve Messaging for Suicide Preven&on: Effec&ve Messaging for Suicide Preven&on: Anara Guard anara@suicideispreventable.org Lessons from a statewide campaign and from a na&onal framework This morning The Know the Signs statewide social marke&ng

More information

2015 Na(onal Medicaid and CHIP Oral Health Symposium. Integra(ng Oral and General Healthcare. Bruce Donoff, DMD, MD. Session #

2015 Na(onal Medicaid and CHIP Oral Health Symposium. Integra(ng Oral and General Healthcare. Bruce Donoff, DMD, MD. Session # MSDA Medicaid CHIP State Dental Association 2015 Na(onal Medicaid and CHIP Oral Health Symposium Session # Integra(ng Oral and General Healthcare Bruce Donoff, DMD, MD Washington Marrio4 Wardman Park Tuesday,

More information

Caveats and Recommendations for Use of Operational Electronic Health Record Data for Research and Quality Measurement

Caveats and Recommendations for Use of Operational Electronic Health Record Data for Research and Quality Measurement Caveats and Recommendations for Use of Operational Electronic Health Record Data for Research and Quality Measurement References William Hersh, MD, FACP, FACMI Diplomate, Clinical Informatics, American

More information

Suicide Care in Systems Framework: National Action Alliance Clinical Care and Intervention Task Force

Suicide Care in Systems Framework: National Action Alliance Clinical Care and Intervention Task Force Suicide Care in Systems Framework: National Action Alliance Clinical Care and Intervention Task Force David A. Jobes, Ph.D., ABPP Professor of Psychology Associate Director of Clinical Training The Catholic

More information

An Introduc+on to Cancer Care at Kaiser Permanente Northwest. Phoebe E. Harvey, MD Chief, Hematology/Oncology Medical Director, Cancer Service Line

An Introduc+on to Cancer Care at Kaiser Permanente Northwest. Phoebe E. Harvey, MD Chief, Hematology/Oncology Medical Director, Cancer Service Line An Introduc+on to Cancer Care at Kaiser Permanente Northwest Phoebe E. Harvey, MD Chief, Hematology/Oncology Medical Director, Cancer Service Line April 16, 2016 Agenda Overview and history of KP Northwest

More information

Population Health: The Path from Volume to Value

Population Health: The Path from Volume to Value AZ Rural & Public Health Policy Forum Population Health: The Path from Volume to Value Mark Carroll, MD January 14, 2015 International Comparison of Spending on Health, 1980 2010 Average spending on health

More information

E. Scafato C. Gandin, L. Galluzzo, S. Ghirini, S. Martire, R. Scipione Istituto Superiore di Sanità, Italy

E. Scafato C. Gandin, L. Galluzzo, S. Ghirini, S. Martire, R. Scipione Istituto Superiore di Sanità, Italy Guidelines to support early identification and brief interventions for alcohol use disorders in Europe: overview of RARHA survey results and of other EU projects E. Scafato C. Gandin, L. Galluzzo, S. Ghirini,

More information

Maternal Mortality and HIV: Examining Research through a Programma;c Lens. Day 1 Recap

Maternal Mortality and HIV: Examining Research through a Programma;c Lens. Day 1 Recap Maternal Mortality and HIV: Examining Research through a Programma;c Lens Day 1 Recap Introduc;on Every day, approximately 800 women die from preventable causes related to pregnancy and childbirth. 99%

More information

Global health; understanding, approach and major issues

Global health; understanding, approach and major issues Global health; understanding, approach and major issues Gabriel Gulis Unit of health promotion research Institute of public health, Faculty of medical sciences University of Southern Denmark Esbjerg, Denmark

More information

Care of Diabe+c Pa+ents in the Hospital Se6ng

Care of Diabe+c Pa+ents in the Hospital Se6ng Care of Diabe+c Pa+ents in the Hospital Se6ng 1/11/2011 Kathia Desronvil, BSN, MSN, FNP- BC Hospitalist, Internal Medicine Department Nash General Hospital Rocky Mount, NC 27616 (H) 919-890- 5561; (C)

More information

1. ATHENA Network, AVAC, and Salamander Trust with UN Women, undertook this mul>-stage review of the global status of access to an>retroviral therapy

1. ATHENA Network, AVAC, and Salamander Trust with UN Women, undertook this mul>-stage review of the global status of access to an>retroviral therapy 1. ATHENA Network, AVAC, and Salamander Trust with UN Women, undertook this mul>-stage review of the global status of access to an>retroviral therapy (ART) for women living with HIV 2. This is the first

More information

Understanding. Design & Sta/s/cs. in Clinical Trials

Understanding. Design & Sta/s/cs. in Clinical Trials Understanding Design & Sta/s/cs in Clinical Trials 1 Why bother? 2 Experience- Based Medicine? Benjamin Rush Father of American Psychiatry 3 Experience- Based Medicine? Supported blood- lejng as treatment

More information

Webinar Series Its All About the Interac0on Strategies for Pragma2c Organiza2on of Communica2on Systems PART 1

Webinar Series Its All About the Interac0on Strategies for Pragma2c Organiza2on of Communica2on Systems PART 1 Webinar Series Its All About the Interac0on Strategies for Pragma2c Organiza2on of Communica2on Systems PART 1 Presented by: Jane Goetz, Au2sm Coordinator & Lori Chambers, Regional Systems Coordinator

More information

Sets, Logic, and Probability As Used in Decision Support Systems

Sets, Logic, and Probability As Used in Decision Support Systems Sets, Logic, and Probability As Used in Decision Support Systems HAP 752 Advanced Health Informa6on Systems Janusz Wojtusiak, PhD George Mason University Spring 2014 Part of the inhumanity of the computer

More information

For Objec*ve Causal Inference, Design Trumps Analysis. Donald B. Rubin Department of Sta*s*cs Harvard University 16 March 2012

For Objec*ve Causal Inference, Design Trumps Analysis. Donald B. Rubin Department of Sta*s*cs Harvard University 16 March 2012 For Objec*ve Causal Inference, Design Trumps Analysis Donald B. Rubin Department of Sta*s*cs Harvard University 16 March 2012 1 Prologue to Objec*ve Causal Inference in Observa*onal Studies My Introduc*on

More information

Program: Module 2: Diagnosis and Investigation of HF and Practical Case Studies Treatment of Heart Failure and Practical Case Studies

Program: Module 2: Diagnosis and Investigation of HF and Practical Case Studies Treatment of Heart Failure and Practical Case Studies Program: Module 1: Definition and Classification Epidemiology of Heart Failure Pathophysiology of Heart Failure Specific Diseases causing Heart Failure and practical case studies Module 2: Diagnosis and

More information

Should Me*ormin be contraindicated in pa4ents with CKD? TAYLOR MCBRIDE UNIVERSITY OF TEXAS/HEB PGY-1 COMMUNITY PHARMACY RESIDENT

Should Me*ormin be contraindicated in pa4ents with CKD? TAYLOR MCBRIDE UNIVERSITY OF TEXAS/HEB PGY-1 COMMUNITY PHARMACY RESIDENT Should Me*ormin be contraindicated in pa4ents with CKD? TAYLOR MCBRIDE UNIVERSITY OF TEXAS/HEB 2018-2019 PGY-1 COMMUNITY PHARMACY RESIDENT 1 Objec4ves Understand the changes to Me*ormin labeled use in

More information

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center at the Maritime Institute Pharmacy-Driven Inpatient

More information

The Data- Rich, Information- Driven Future of Healthcare

The Data- Rich, Information- Driven Future of Healthcare The Data- Rich, Information- Driven Future of Healthcare William Hersh, MD Professor and Chair Department of Medical Informatics & Clinical Epidemiology Oregon Health & Science University Portland, OR,

More information

Ohio Medical Marijuana Control Program

Ohio Medical Marijuana Control Program Ohio Medical Marijuana Control Program Guiding Principles Ohio Medical Marijuana Control Program is: 1. Pa;ent-centered and safe 2. Responsive, data-driven, and transparent 3. Flexible, scalable, and sustainable

More information

Appendix Identification of Study Cohorts

Appendix Identification of Study Cohorts Appendix Identification of Study Cohorts Because the models were run with the 2010 SAS Packs from Centers for Medicare and Medicaid Services (CMS)/Yale, the eligibility criteria described in "2010 Measures

More information

The Digital Age of HP2020

The Digital Age of HP2020 The Digital Age of HP2020 Theresa Devine, MPH Office of Disease Preven0on and Health Promo0on (HHS) Sarah Pomerantz, MPH CommunicateHealth, Inc. Ma5 Allen CommunicateHealth, Inc. This Morning s Agenda

More information

Are We Ready for ASAM? Does the ASAM Level of Care Designa:ons Correspond to Clinical Judgment?

Are We Ready for ASAM? Does the ASAM Level of Care Designa:ons Correspond to Clinical Judgment? Are We Ready for ASAM? Does the ASAM Level of Care Designa:ons Correspond to Clinical Judgment? Desirée A. Crevecoeur-MacPhail, PhD UCLA Integrated Substance Abuse Programs Semel Ins@tute for Neuroscience

More information

Medicare & Medicaid EHR Incentive Programs

Medicare & Medicaid EHR Incentive Programs Medicare & Medicaid EHR Incentive Programs Stage 2 NPRM Overview Robert Anthony March 6, 2012 Proposed Rule Everything discussed in this presentation is part of a notice of proposed rulemaking (NPRM).

More information

Agenda. Clinical and Operational Considerations for Appropriate Telepsychiatry Best Prac/ces for Designing and Implemen/ng Telebehavioral Health

Agenda. Clinical and Operational Considerations for Appropriate Telepsychiatry Best Prac/ces for Designing and Implemen/ng Telebehavioral Health Clinical and Operational Considerations for Appropriate Telepsychiatry Best Prac/ces for Designing and Implemen/ng Telebehavioral Health RCPA- Fall 2014 Geoffrey Boyce, MBA Execu/ve Director InSight James

More information

Clinical Research Project Design and Guidelines: Choosing a Research Ques8on

Clinical Research Project Design and Guidelines: Choosing a Research Ques8on Clinical Research Project Design and Guidelines: Choosing a Research Ques8on Odunayo M. Oluwatosin, FMCS (Nig) Department of Plas?c Surgery University College Hospital Ibadan 1 Learning outcome: by the

More information

Information Technology-Driven Analytics: The Link Between Data Aggregation, Analytics and EHRs. Ronald A. Paulus, MD President and CEO June 27, 2011

Information Technology-Driven Analytics: The Link Between Data Aggregation, Analytics and EHRs. Ronald A. Paulus, MD President and CEO June 27, 2011 Information Technology-Driven Analytics: The Link Between Data Aggregation, Analytics and EHRs Ronald A. Paulus, MD President and CEO June 27, 2011 1 Summary Analytics and EHRs are co-dependent and complementary

More information

Training + U*lizing Student Staff as Ac*ve Bystanders

Training + U*lizing Student Staff as Ac*ve Bystanders Training + U*lizing Student Staff as Ac*ve Bystanders Ka*e Sorokas Kent State University ksorokas@kent.edu Jennifer O Connell Kent State University joconne5@kent.edu Outline Descrip*on of Kent State University

More information

Diabetes Self- management Educa4on and Support (DSME/S)

Diabetes Self- management Educa4on and Support (DSME/S) Improving Patient Care Through Diabetes Self- management Education Davida F. Kruger, MSN, APN-BC, BC-ADM Certified Nurse Practitioner Henry Ford Health System Division of Endocrinology, Diabetes, Bone

More information

Objec0ves. Next Genera0on Biomarkers in Prostate Cancer. UBC Department of Urologic Sciences. Jennifer Locke, R2 January 28, 2015

Objec0ves. Next Genera0on Biomarkers in Prostate Cancer. UBC Department of Urologic Sciences. Jennifer Locke, R2 January 28, 2015 UBC Department of Urologic Sciences Next Genera0on Biomarkers in Prostate Cancer Jennifer Locke, R2 January 28, 2015 Objec0ves 1. Highlight why biomarkers are important in prostate cancer management 2.

More information

SIMPATH Y. S*mula*ng Innova*on Management of Polypharmacy and Adherence in the Elderly Simpathy

SIMPATH Y. S*mula*ng Innova*on Management of Polypharmacy and Adherence in the Elderly Simpathy S*mula*ng Innova*on Management of Sunfrail Transla1onal workshop Understanding and caring for frailty and mul1morbidity Bologna, March 22nd 2016 S*mula*ng Innova*on Management of Polypharmacy and Adherence

More information

Risk Assessment in IPC. Key Defini>ons. Risk Assessment in IPC

Risk Assessment in IPC. Key Defini>ons. Risk Assessment in IPC Dr Nizam Damani MSc, MBBS, FRCPath., FRCPI, CIC, DipHIC Associate Medical Director Infec>on Preven>on and Control Southern Health & Social Care Trust, Portadown, UK Senior Lecturer, Queen s University,

More information

Stacie Fruth, PT, DHSc, OCS Michael Brickens, PT Tim Ellender, MD Jenny Gojmerac- Owens, NP Julie Welch, MD. Stacie Fruth, PT, DHSc, OCS

Stacie Fruth, PT, DHSc, OCS Michael Brickens, PT Tim Ellender, MD Jenny Gojmerac- Owens, NP Julie Welch, MD. Stacie Fruth, PT, DHSc, OCS Physical Therapists on the Emergency Department Team: PT and MD Perspec8ves Stacie Fruth, PT, DHSc, OCS Michael Brickens, PT Tim Ellender, MD Jenny Gojmerac- Owens, NP Julie Welch, MD Combined Sec,ons

More information

Polypharmacy Reviews in the real world

Polypharmacy Reviews in the real world S P S Community Health Services Specialist Pharmacy Service Medicines Use and Safety Polypharmacy Reviews in the real world Lelly Oboh Consultant Pharmacist, Care of Older People Guys & St Thomas NHS Founda@on

More information

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza Aeron Hurt WHO Collabora@ng Centre for Reference and Research on Influenza, Melbourne, Australia www.influenzacentre.org NA inhibitor

More information